Almirall, S.A. (OTCMKTS:LBTSF) Short Interest Update

Almirall, S.A. (OTCMKTS:LBTSF – Get Rating) was the target of a large drop in short interest in April. As of April 15th, there was short interest totalling 227,300 shares, a drop of 5.0% from the March 31st total of 239,300 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Almirall Price Performance

Shares of OTCMKTS LBTSF opened at $9.68 on Wednesday. Almirall has a fifty-two week low of $9.28 and a fifty-two week high of $9.68. The stock’s 50-day simple moving average is $9.68 and its 200-day simple moving average is $9.58.

Get Almirall alerts:

About Almirall

(Get Rating)

Almirall, SA, a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations.

See Also

• Get a free copy of the StockNews.com research report on Almirall (LBTSF)
• Do Bank Stocks Go Up When Interest Rates Rise?
• How to Invest in Vertical Farming Stocks
• Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding
• Ecolab: Slow And Steady Wins The Race 
• MGM’s Hot Hand Is All In For A Rally, After This Small Break

Receive News & Ratings for Almirall Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Almirall and related companies with MarketBeat.com's FREE daily email newsletter.